Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types

BACKGROUND: Epidermal growth factor receptor (EGFR) mutations in non–small-cell lung cancer predict sensitivity to EGFR tyrosine kinase inhibitors (TKIs). EGFR mutation types are associated with efficacy of EGFR TKIs. We investigated the clinical outcomes of afatinib, erlotinib, and gefitinib accord...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Park, Sojung, Lee, Sung Yong, Kim, Dojin, Sim, Yun Su, Ryu, Jeong-Seon, Choi, Juwhan, Lee, Su Hwan, Ryu, Yon Ju, Lee, Jin Hwa, Chang, Jung Hyun
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7802134/
https://ncbi.nlm.nih.gov/pubmed/33430803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07765-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados